MEDICAREX
DEAD

Serial Number

98617169

Owner

Hojeong Yu

Attorney

Douglas L. Lineberry

Filing Date

Jun 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MEDICAREX Trademark

Serial Number: 98617169

MEDICAREX is a trademark filed by Hojeong Yu on June 25, 2024. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Hojeong Yu (2 trademarks)

9550 Community Commons LN
Charlotte, NC 28277

Entity Type: 01

Trademark Details

Filing Date

June 25, 2024

Registration Date

Not Registered

Goods & Services

Electronic apparatus for use in the treatment of aqueous systems, namely, for analysis of the system conditions for the purpose of applying the appropriate chemical treatment; Electronic products for the generation, measurement, and analysis of audio signals, namely, audio analyzers; Recorded computer software platforms for evaluation and documentation of test results in the field of drug and biochemical substance testing and for storing, evaluating and documenting results of drug and biochemical substance testing; Recorded computer software using artificial intelligence for evaluation and documentation of test results in the field of drug and biochemical substance testing and for storing, evaluating and documenting results of drug and biochemical substance testing; Recorded computer operating software; Recorded computer simulation software for modeling drug and biochemical sub; Recorded software, capable of functioning offline, for evaluation and documentation of test results in the field of drug and biochemical substance testing and for storing, evaluating and documenting results of drug and biochemical substance testing; Downloadable cloud-based software for analyzing chemical tests; Recorded computer application software for mobile devices and handheld, laptop, and desk computers, namely, software for storing, evaluating and documentation of the result of drug tests and evaluation and documentation of drug and biochemical substance tests; Scientific instrumentation for measuring concentrations of chemicals in water; Scientific instrumentation for measuring biochemical substance levels[not for medical use]; Scientific instruments, namely, electronic analyzers for measuring, testing and detecting contaminants and environmental pollutants; Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics, and contaminants; Scientific instruments, namely, electronic analyzers for testing consumer products for the presence of contaminants; Technical measuring, testing and checking apparatus and instruments for measuring, testing and checking the temperature, pressure, quantity and concentration of gas and liquids

Chemical diagnostic reagents for industrial purposes; Chemical diagnostic reagents for scientific purposes; Chemicals for use in industry and science; In vitro diagnostic reagents for scientific purposes; Reagents for testing solutions, other than for medical or veterinary use; Biochemicals for in vitro and in vivo scientific use; Diagnostic preparations for in vitro testing for scientific use

Diagnostic apparatus for medical purposes used in medical laboratories for testing and collecting and testing biological fluids for the presence of drugs, drug metabolites and biochemical substances; Medical diagnostic apparatus for testing and collecting and testing biological fluids for the presence of drugs, drug metabolites and biochemical substances; Body composition analyzers for medical purposes; Breath gas analyzers for medical diagnostics; Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Hematology analyzers for medical diagnostic uses

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 3, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 3, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2025 NWOS
NEW APPLICATION ENTERED
Jun 25, 2024 NWAP